Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration

被引:109
作者
Yurube, Takashi [1 ]
Takada, Toru [1 ]
Suzuki, Teppei [1 ]
Kakutani, Kenichiro [1 ]
Maeno, Koichiro [1 ]
Doita, Minoru [1 ]
Kurosaka, Masahiro [1 ]
Nishida, Kotaro [1 ]
机构
[1] Kobe Univ, Dept Orthopaed Surg, Grad Sch Med, Kobe, Hyogo 657, Japan
关键词
NECROSIS-FACTOR-ALPHA; LOW-BACK-PAIN; IN-VIVO; GENE-EXPRESSION; LUMBAR DISC; NUCLEUS PULPOSUS; PROTEOGLYCAN SYNTHESIS; CARTILAGE DEGRADATION; DYNAMIC COMPRESSION; ANNULUS FIBROSUS;
D O I
10.1186/ar3764
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The longitudinal degradation mechanism of extracellular matrix (ECM) in the interbertebral disc remains unclear. Our objective was to elucidate catabolic and anabolic gene expression profiles and their balances in intervertebral disc degeneration using a static compression model. Methods: Forty-eight 12-week-old male Sprague-Dawley rat tails were instrumented with an Ilizarov-type device with springs and loaded statically at 1.3 MPa for up to 56 days. Experimental loaded and distal-unloaded control discs were harvested and analyzed by real-time reverse transcription-polymerase chain reaction (PCR) messenger RNA quantification for catabolic genes [matrix metalloproteinase (MMP)-1a, MMP-2, MMP-3, MMP-7, MMP-9, MMP-13, a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-4, and ADAMTS-5], anti-catabolic genes [tissue inhibitor of metalloproteinases (TIMP)-1, TIMP-2, and TIMP-3], ECM genes [aggrecan-1, collagen type 1-alpha 1, and collagen type 2-alpha 1], and pro-inflammatory cytokine genes [tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 alpha, IL-1 beta, and IL-6]. Immunohistochemistry for MMP-3, ADAMTS-4, ADAMTS-5, TIMP-1, TIMP-2, and TIMP-3 was performed to assess their protein expression level and distribution. The presence of MMP- and aggrecanase-cleaved aggrecan neoepitopes was similarly investigated to evaluate aggrecanolytic activity. Results: Quantitative PCR demonstrated up-regulation of all MMPs and ADAMTS-4 but not ADAMTS-5. TIMP-1 and TIMP-2 were almost unchanged while TIMP-3 was down-regulated. Down-regulation of aggrecan-1 and collagen type 2-alpha 1 and up-regulation of collagen type 1-alpha 1 were observed. Despite TNF-alpha elevation, ILs developed little to no up-regulation. Immunohistochemistry showed, in the nucleus pulposus, the percentage of immunopositive cells of MMP-cleaved aggrecan neoepitope increased from 7 through 56 days with increased MMP-3 and decreased TIMP-1 and TIMP-2 immunopositivity. The percentage of immunopositive cells of aggrecanase-cleaved aggrecan neoepitope increased at 7 and 28 days only with decreased TIMP-3 immunopositivity. In the annulus fibrosus, MMP-cleaved aggrecan neoepitope presented much the same expression pattern. Aggrecanase-cleaved aggrecan neoepitope increased at 7 and 28 days only with increased ADAMTS-4 and ADAMTS-5 immunopositivity. Conclusions: This rat tail sustained static compression model mimics ECM metabolic imbalances of MMPs, aggrecanases, and TIMPs in human degenerative discs. A dominant imbalance of MMP-3/TIMP-1 and TIMP-2 relative to ADAMTS-4 and ADAMTS-5/TIMP-3 signifies an advanced stage of intervertebral disc degeneration.
引用
收藏
页数:14
相关论文
共 79 条
[31]   Immunohistochemical study of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in human intervertebral discs [J].
Kanemoto, M ;
Hukuda, S ;
Komiya, Y ;
Katsuura, A ;
Nishioka, J .
SPINE, 1996, 21 (01) :1-8
[32]   Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity [J].
Karsdal, Morten A. ;
Madsen, Suzi H. ;
Christiansen, Claus ;
Henriksen, Kim ;
Fosang, Amanda J. ;
Sondergaard, Bodil C. .
ARTHRITIS RESEARCH & THERAPY, 2008, 10 (03)
[33]   TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5) [J].
Kashiwagi, M ;
Tortorella, M ;
Nagase, H ;
Brew, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12501-12504
[34]   New in vivo animal model to create intervertebral disc degeneration and to investigate the effects of therapeutic strategies to stimulate disc regeneration [J].
Kroeber, MW ;
Unglaub, F ;
Wang, HL ;
Schmid, C ;
Thomsen, M ;
Nerlich, A ;
Richter, W .
SPINE, 2002, 27 (23) :2684-2690
[35]   Catabolic cytokine expression in degenerate and herniated human intervertebral discs:: IL-1β and TNFα expression profile [J].
Le Maitre, Christine Lyn ;
Hoyland, Judith Alison ;
Freemont, Anthony J. .
ARTHRITIS RESEARCH & THERAPY, 2007, 9 (04)
[36]   The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration [J].
Le Maitre, CL ;
Freemont, AJ ;
Hoyland, JA .
ARTHRITIS RESEARCH & THERAPY, 2005, 7 (04) :R732-R745
[37]   Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc [J].
Le Maitre, CL ;
Freemont, AJ ;
Hoyland, JA .
JOURNAL OF PATHOLOGY, 2004, 204 (01) :47-54
[38]   Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro [J].
Little, CB ;
Flannery, CR ;
Hughes, CE ;
Mort, JS ;
Roughley, PJ ;
Dent, C ;
Caterson, B .
BIOCHEMICAL JOURNAL, 1999, 344 :61-68
[39]   Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method [J].
Livak, KJ ;
Schmittgen, TD .
METHODS, 2001, 25 (04) :402-408
[40]   1998 Volvo Award winner in biomechanical studies -: Compression-induced degeneration of the intervertebral disc:: An in vivo mouse model and finite-element study [J].
Lotz, JC ;
Colliou, OK ;
Chin, JR ;
Duncan, NA ;
Liebenberg, E .
SPINE, 1998, 23 (23) :2493-2506